Table 2.
Interaction with the healthcare team |
---|
Age-appropriate education and awareness of treatment objectives and the importance of adherence, particularly when administration shifts from caregiver to child (16, 29, 31) |
Increased patient engagement, such as in selecting the device (16, 30) and in shared decision-making (11) |
Ongoing feedback of treatment efficacy, to encourage compliance (16) |
Adherence reminder tools |
Electronic injection reminders, mobile phone reminders, and applications (13) |
Gamified interventions that include goal setting, incentive-based engagement, and education (13) |
Real-time monitoring of adherence using internet-connected devices (13) |
Use of an electronic monitoring device to track adherence (12, 13, 23) |
Device |
Improvements in device design that reduce pain (29)/needle anxiety (32) and increase convenience (16) |
Product |
A product that does not require cold storage (i.e., storage-flexible rhGH) (21) |
Reduction in the number of injections from daily to weekly (14) |
rhGH, recombinant human growth hormone.